Acute attacks of “thunderstorm asthma” can worsen pollen allergies and exacerbate respiratory conditions. And as climate ...

Severe asthma affects roughly 2 million people in the United States. It is hard to control — even with inhaled steroid medicines and additional therapies. More than 80% of cases are linked to type 2 ...

Severe asthma is already treatable with a monthly injectable GSK drug, the blockbuster product Nucala. A new FDA approval gives the drugmaker the opportunity to reach patients with a different ...

Please provide your email address to receive an email when new articles are posted on . 6.5% of patients with mild asthma had at least one acute exacerbation in the year after the index date.

The FDA approved depemokimab (Exdensur) as the first ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype, GSK announced. The ...

SAN ANTONIO — For children, a visit to the emergency department for an asthma attack is a red flag for future acute-care visits, and could be used to identify patients who might benefit from ...

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use has recommended the granting of a marketing authorization for Exdensur (depemokimab, GlaxoSmithKline) for severe ...

Fifteen years ago, former Cincinnati Bengals running back Elbert “Ickey” Woods lost his 16 year old son, Jovante, to an acute asthma attack. Now, he has channeled his grief into action through the ...

A medicine that has been used for decades to treat asthma may one day help people with a serious liver disease that affects ...